Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Current Medicinal Chemistry
|
April 28, 2005
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance
Muzahir H Tayebjee, Gregory Y H Lip, Robert J MacFadyen
International Journal of Cardiology
|
April 8, 2006
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients
Deepak Goyal, Muzahir Tayebjee, Gregory Y H Lip, et al.
European Heart Journal
|
March 31, 2007
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
Rumi Jaumdally, Chetan Varma, Robert J Macfadyen, et al.
Cardiovascular Drugs and Therapy
|
September 27, 2007
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure
Ali Hamaad, Gregory Y H Lip, Deborah Nicholls, et al.
Expert Opinion on Pharmacotherapy
|
July 22, 2004
Diastolic heart failure: recognition, diagnosis and management
Deepak Goyal, Anirban Choudhary, Gregory Y H Lip, et al.
Cardiovascular Drugs and Therapy
|
September 6, 2005
Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure
Ali Hamaad, Mike Sosin, Gregory Y H Lip, et al.
Current Pharmaceutical Design
|
May 30, 2006
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management
Hoong Sern Lim, Robert J MacFadyen, George Bakris, et al.
Journal of Thrombosis and Thrombolysis
|
January 16, 2007
Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease
Rumi J Jaumdally, Chetan Varma, Robert J MacFadyen, et al.
Biomarkers in Medicine
|
May 19, 2010
Repeated assessment of physical biomeasures or blood biomarkers for the definition of volume status and cardiac loading in LVSD
Marie Jennyfer Ng Kam Chuen, Gregory Y H Lip, Robert J MacFadyen
Cardiovascular Drugs and Therapy
|
November 8, 2006
Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients
Ali Hamaad, W Kaeng Lee, Gregory Y H Lip, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Current Medicinal Chemistry
|
April 28, 2005
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance
Muzahir H Tayebjee, Gregory Y H Lip, Robert J MacFadyen
International Journal of Cardiology
|
April 8, 2006
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients
Deepak Goyal, Muzahir Tayebjee, Gregory Y H Lip, et al.
European Heart Journal
|
March 31, 2007
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
Rumi Jaumdally, Chetan Varma, Robert J Macfadyen, et al.
Cardiovascular Drugs and Therapy
|
September 27, 2007
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure
Ali Hamaad, Gregory Y H Lip, Deborah Nicholls, et al.
Expert Opinion on Pharmacotherapy
|
July 22, 2004
Diastolic heart failure: recognition, diagnosis and management
Deepak Goyal, Anirban Choudhary, Gregory Y H Lip, et al.
Cardiovascular Drugs and Therapy
|
September 6, 2005
Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure
Ali Hamaad, Mike Sosin, Gregory Y H Lip, et al.
Current Pharmaceutical Design
|
May 30, 2006
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management
Hoong Sern Lim, Robert J MacFadyen, George Bakris, et al.
Journal of Thrombosis and Thrombolysis
|
January 16, 2007
Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease
Rumi J Jaumdally, Chetan Varma, Robert J MacFadyen, et al.
Biomarkers in Medicine
|
May 19, 2010
Repeated assessment of physical biomeasures or blood biomarkers for the definition of volume status and cardiac loading in LVSD
Marie Jennyfer Ng Kam Chuen, Gregory Y H Lip, Robert J MacFadyen
Cardiovascular Drugs and Therapy
|
November 8, 2006
Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients
Ali Hamaad, W Kaeng Lee, Gregory Y H Lip, et al.
Page
of 5